These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 247480)

  • 1. Nursing implications of cis-platinum therapy.
    Higgins NM
    Oncol Nurs Forum; 1978; 5(1-2):3-4. PubMed ID: 247480
    [No Abstract]   [Full Text] [Related]  

  • 2. Cis-platinum: a brief review of its use, and nursing guidelines.
    Ellington OB
    Cancer Nurs; 1978 Oct; 1(5):403-6. PubMed ID: 359123
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
    Vietti TJ; Nitschke R; Starling KA; van Eys J
    Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cis-Dichlorodiammineplatinum(II) in childhood cancer.
    Freeman AI; Ettinger LJ; Brecher ML
    Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
    Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
    Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study.
    Nitschke R; Fagundo R; Berry DH; Falletta JM
    Cancer Treat Rep; 1979 Mar; 63(3):497-9. PubMed ID: 427829
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
    Chary KK; Higby DJ; Henderson ES; Swinerton KD
    Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
    Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
    Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New frontiers in cancer chemotherapy: cis-platinum].
    Sulkes A; Peretz T; Rizel S; Yahalom Y; Brian S
    Harefuah; 1986 Jan; 110(2):90-3. PubMed ID: 3516812
    [No Abstract]   [Full Text] [Related]  

  • 10. Organo-platinum complexes as antitumor agents (review).
    Hill JM; Speer RJ
    Anticancer Res; 1982; 2(3):173-86. PubMed ID: 6751211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
    Crovato E; Salvini R
    Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cis-platinum ototoxicity in children.
    Pasic TR; Dobie RA
    Laryngoscope; 1991 Sep; 101(9):985-91. PubMed ID: 1886448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cis-platinum in the treatment of testicular and other cancers.
    Williams SD; Einhorn LH
    Adv Intern Med; 1982; 27():531-45. PubMed ID: 7041553
    [No Abstract]   [Full Text] [Related]  

  • 14. [Platinum derivatives in the clinical chemotherapy of malignant tumors].
    Gorbunova VA
    Vopr Onkol; 1982; 28(5):38-43. PubMed ID: 7201207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cis-diamminedichloroplatinum secretion by the human kidney with probenecid.
    Jacobs C; Coleman CN; Rich L; Hirst K; Weiner MW
    Cancer Res; 1984 Aug; 44(8):3632-5. PubMed ID: 6540140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
    Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
    Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump].
    Gestin-Boyer C; René C; Cupissol D; Tep A; Bressolle F; Bres J; Brun S; Serrou B; Pujol H
    C R Seances Soc Biol Fil; 1989; 183(3):263-8. PubMed ID: 2532561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin in the treatment of head and neck squamous carcinoma.
    Cunningham JD
    Ear Nose Throat J; 1983 Apr; 62(4):199-205. PubMed ID: 6345131
    [No Abstract]   [Full Text] [Related]  

  • 19. Cisplatin: a review of toxicities and therapeutic applications.
    Barabas K; Milner R; Lurie D; Adin C
    Vet Comp Oncol; 2008 Mar; 6(1):1-18. PubMed ID: 19178659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin in the treatment of malignant tumors].
    Wang QL
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):461-4. PubMed ID: 6426911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.